Oral semaglutide is a tablet that helps manage blood sugar and support weight loss
Adverse effects associated with dosing errors have included nausea, vomiting, abdominal pain, fainting, headache, dehydration, gallstones, and inflammation of the pancreas
The safety data for semaglutide microdosing is also limited because microdosing protocols are not supported by large-scale clinical trials or rigorous testing
In just four weeks, GLP-1 medication starts to work by reducing appetite, increasing feelings of fullness, and improving blood sugar control
Weight Loss Progress It is recommended to take semaglutide until you reach your desired weight
Signal Transduction and Targeted Therapy 8(2): 396